Atul Saran - Feb 22, 2022 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Corp Dev, GC & Secretary
Signature
/s/ S. Scott Lieberman, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Feb 22, 2022
Transactions value $
-$88,007
Form type
4
Date filed
2/24/2022, 05:51 PM
Next filing
Feb 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Award $0 +1.84K +4.1% $0.00 46.6K Feb 22, 2022 Direct F1
transaction EBS Common Stock Tax liability -$88K -2.08K -4.47% $42.23 44.5K Feb 22, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. On February 22, 2022, the final certification date, the Compensation Committee certified the achievement of the 2019-2021 PSUs at a payout factor of 136.14% of target resulting in the actual award of 6,917 shares of common stock, which is in excess of the 5,081 shares previously reported on February 28, 2019.
F2 Represents shares of common stock withheld to pay taxes.